Open AccessWillingness to Pay for Childhood Malaria Vaccine Among Caregivers of Under-Five Children in Northwest Ethiopia
Author(s) -
Yohannes Wagnew,
Tsega Hagos,
Berhanemeskel Weldegerima,
Ayal Debie
Publication year - 2021
Publication title -
clinicoeconomics and outcomes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.591
H-Index - 27
ISSN - 1178-6981
DOI - 10.2147/ceor.s299050
Subject(s) - malaria , medicine , willingness to pay , residence , vaccination , environmental health , malaria vaccine , contingent valuation , cross sectional study , disease , demography , immunology , plasmodium falciparum , pathology , sociology , economics , microeconomics
Malaria, a protozoan disease caused by the genus Plasmodium , is responsible for serious illnesses and death across the world. RTS, S/AS01 (Mosquirix™) is a recombinant protein-based malaria vaccine valuable for the prevention and control of the disease. However, studies done so far on the willingness to pay (WTP) malaria vaccine have been inadequate to inform policy-makers.